Study of "Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors". Bhin et al

Name: Study of "Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors". Bhin et al
Creator: Jinhyuk Bhin
Published: 2023-05-23T06:03:23.933Z
Keywords: Fluorescence, Western Blot, Immunohistochemistry, Biologic Imaging

Bhin, Jinhyuk; Paes Dias, Mariana; Gogola, Ewa; Jonkers, Jos; Rottenberg, Sven

doi:10.17632/vkcnb3rrw6.1

Study of "Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors". Bhin et al

Published: 23 May 2023| Version 1 | DOI: 10.17632/vkcnb3rrw6.1

Contributors:

Jinhyuk Bhin, Mariana Paes Dias, Ewa Gogola, Jos Jonkers, Sven Rottenberg

Description

Raw data required by Cell Reports data archiving and data transparency initiative

Files

Institutions

Antoni van Leeuwenhoek Nederlands Kanker Instituut

Study of "Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors". Bhin et al

Description

Files

Institutions

Categories

Licence